Literature DB >> 21764637

Base excision and nucleotide excision repair pathways in mycobacteria.

Krishna Kurthkoti1, Umesh Varshney.   

Abstract

About a third of the human population is estimated to be infected with Mycobacterium tuberculosis. The bacterium displays an excellent adaptability to survive within the host macrophages. As the reactive environment of macrophages is capable of inducing DNA damage, the ability of the pathogen to safeguard its DNA against the damage is of paramount significance for its survival within the host. Analysis of the genome sequence has provided important insights into the DNA repair machinery of the pathogen, and the studies on DNA repair in mycobacteria have gained momentum in the past few years. The studies have revealed considerable differences in the mycobacterial DNA repair machinery when compared with those of the other bacteria. This review article focuses especially on the aspects of base excision, and nucleotide excision repair pathways in mycobacteria.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21764637     DOI: 10.1016/j.tube.2011.06.005

Source DB:  PubMed          Journal:  Tuberculosis (Edinb)        ISSN: 1472-9792            Impact factor:   3.131


  9 in total

1.  Mycobacterium tuberculosis RecG protein but not RuvAB or RecA protein is efficient at remodeling the stalled replication forks: implications for multiple mechanisms of replication restart in mycobacteria.

Authors:  Roshan Singh Thakur; Shivakumar Basavaraju; Jasbeer Singh Khanduja; K Muniyappa; Ganesh Nagaraju
Journal:  J Biol Chem       Date:  2015-08-14       Impact factor: 5.157

2.  Crystallization and preliminary X-ray studies of MutT1 (MSMEG_2390) from Mycobacterium smegmatis.

Authors:  S M Arif; A G Patil; U Varshney; M Vijayan
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2012-09-26

Review 3.  Methodological and Clinical Aspects of the Molecular Epidemiology of Mycobacterium tuberculosis and Other Mycobacteria.

Authors:  Tomasz Jagielski; Alina Minias; Jakko van Ingen; Nalin Rastogi; Anna Brzostek; Anna Żaczek; Jarosław Dziadek
Journal:  Clin Microbiol Rev       Date:  2016-04       Impact factor: 26.132

4.  Biochemical properties of MutT2 proteins from Mycobacterium tuberculosis and M. smegmatis and their contrasting antimutator roles in Escherichia coli.

Authors:  Pau Biak Sang; Umesh Varshney
Journal:  J Bacteriol       Date:  2013-01-25       Impact factor: 3.490

5.  Characterization of a Mycobacterium smegmatis uvrA mutant impaired in dormancy induced by hypoxia and low carbon concentration.

Authors:  Angela Cordone; Bianca Audrain; Immacolata Calabrese; Daniel Euphrasie; Jean-Marc Reyrat
Journal:  BMC Microbiol       Date:  2011-10-18       Impact factor: 3.605

6.  Rv0004 is a new essential member of the mycobacterial DNA replication machinery.

Authors:  Katherine M Mann; Deborah L Huang; Anna J Hooppaw; Michelle M Logsdon; Kirill Richardson; Hark Joon Lee; Jacqueline M Kimmey; Bree B Aldridge; Christina L Stallings
Journal:  PLoS Genet       Date:  2017-11-27       Impact factor: 5.917

7.  Compromised base excision repair pathway in Mycobacterium tuberculosis imparts superior adaptability in the host.

Authors:  Saba Naz; Shruti Dabral; Sathya Narayanan Nagarajan; Divya Arora; Lakshya Veer Singh; Pradeep Kumar; Yogendra Singh; Dhiraj Kumar; Umesh Varshney; Vinay Kumar Nandicoori
Journal:  PLoS Pathog       Date:  2021-03-19       Impact factor: 6.823

8.  Endonuclease IV Is the major apurinic/apyrimidinic endonuclease in Mycobacterium tuberculosis and is important for protection against oxidative damage.

Authors:  Rupangi Verma Puri; Nisha Singh; Rakesh K Gupta; Anil K Tyagi
Journal:  PLoS One       Date:  2013-08-01       Impact factor: 3.240

9.  Apurinic/apyrimidinic endonucleases of Mycobacterium tuberculosis protect against DNA damage but are dispensable for the growth of the pathogen in guinea pigs.

Authors:  Rupangi Verma Puri; P Vineel Reddy; Anil K Tyagi
Journal:  PLoS One       Date:  2014-05-06       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.